Connect with us

Hi, what are you looking for?

Jewish Business News


George Soros Dumps Biotech

Exclusive Interview With Billionaire Investor George Soros


The biotech sector has been outperforming the S&P 500, and some money managers continue to buy even as others are concerned about a bubble, as reported by Motley Fool.     The iShares  Nasdaq Biotech Index (IBB) has nearly tripled since 2012. However, all good things must come to an end, and this includes rallies in a sector.

Please help us out :
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at
Thank you.

Billionaire investor George Soros has been dumping biotech. Ariad Pharmaceuticals (ARIA) was one stock Soros thinned out. Even though sales for its cancer drug have been strong, its clinical trials have been costly, and Ariad has been spending quite a bit. It is not yet profitable and shareholders are worried about a dilutive secondary offering.

Soros sold all of his shares of Celgene, which has a successful blood cancer drug, Revlimid, trades at a rich and stretched valuation of 60. It might have reached its peak, or at least Soros seems to think so. Soros unloaded 52% of his position in Sarepta after the FDA questioned the veracity of its clinical trials.



You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...


The Movie The Professional is what made Natalie Portman a Lolita.


After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...

VC, Investments

You may not become a millionaire, but there is a lot to learn from George Soros.